The pharmacotherapy of schizophrenia is currently dominated by atypical antipsychotics that primarily target dopaminergic signalling, the dysregulation of which has long been considered to have a ...

Background: Many neuromuscular blockers act as negative allosteric modulators of muscarinic acetylcholine receptors by decreasing affinity and potency of acetylcholine. The neuromuscular blocker ...

Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

A drug that has recently been approved for the treatment of schizophrenia could one day be prescribed to Alzheimer’s patients ...

Acetylcholine is a neurotransmitter that plays a crucial role in cognitive function, memory retention, and muscle control. Whether you’re looking to enhance your mental clarity, focus ...